Figure 1 (Image 01)
Zolmitriptan Spray
Product Images NDC 45802-711
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 45802-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
This is a chart showing the estimated probability of taking an escape medication over the course of 11 hours from the initial dose. The chart compares two nasal sprays, one containing 25 NG and the other containing 55.0 MG, along with a placebo. The percentage of probability ranges from 0% to 100%.*
Figure 3 (Image 03)
This appears to be a table showing the results of a clinical trial comparing Zolmitriptan 5 mg with a placebo in 231 participants. The table also includes data on the estimated probability of rescue medication use at various time points post-dose.*
Figure-a (Image 04)
Figure B (Image 05)
Figure-c (Image 06)
Figure D (Image 07)
Carton-7t0 (Image 09)
Chemical-structure (Image 10)
Serialization-template (Image 12)
This text provides fields to insert the serial number, lot number, and expiration date for a product. Without knowledge of the type of product in question, this information is too general to provide any specific useful description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
